Clinical Guidelines

AHA Calls for Individualized Approach to Pediatric Cardiovascular Genetic Testing

Genetic testing of children can play a key role in determining a child’s risk of developing heritable cardiovascular disease. But testing should be limited to children with a high likelihood of … [Read more...]

Genetic Testing

Three Common PGx Compliance Traps for Laboratories to Avoid

By Adam M. Walters Walters Law, P.C. In recent years, many clinical laboratories have started offering Pharmacogenetics Testing (PGx) to assist physicians in avoiding prescribing medication … [Read more...]

Reproductive Testing

Don’t Rely on Biomarker Tests to Predict Risk of Premature Births, Warns AACC

After steadily declining, the rate of spontaneous preterm births in the U.S. rose to 10 percent in 2018. Preventing premature births would save the nation over $26 billion per year. However, … [Read more...]

EMERGING TESTS

DNA Methylation Tests May Be the Next Game Changer in Low Cost, Noninvasive Cancer Testing

As liquid biopsies that analyze cell-free DNA (cfDNA) continue to gain traction in oncology, several companies are stepping up efforts to develop other noninvasive early cancer detection tests using … [Read more...]

Exact Sciences Scores Big as USPSTF Lowers Colorectal Cancer Screening Start Age to 45

Wouldn’t it be great if a government health task force recommended that people use the kind of test you create every year? Something like that just happened to Exact Sciences, maker of the Cologuard … [Read more...]

Genetic Testing

AMP Survey Finds that Inadequate Reimbursement Hinders Use of Molecular Diagnostics

Inadequate reimbursement is hindering utilization of molecular testing. That is the conclusion of a new survey from the Association of Molecular Pathology (AMP). Survey respondents also suggested that … [Read more...]

Emerging Tests

New Genomic Test Can Eliminate Up to One-Third of Medically Unnecessary Prostate Cancer Biopsies

Genetic testing has been shown to be effective in detecting prostate cancer and eliminating the need for unnecessary biopsies. And even though the current commercial market for such tests is crowded, … [Read more...]

Genetic Testing

New Study Shows Viability of Using Ancestry to Compare Prostate Cancer Risk Across Populations

Ancestry has been shown to be a risk factor for prostate cancer. Unfortunately, we know very little about why men of certain races and ethnicities are more prone to get it, let alone how to use … [Read more...]

Emerging Tests

New Genomic Test Can Eliminate Up to One-Third of Medically Unnecessary Prostate Cancer Biopsies

Genetic testing has been shown to be effective in detecting prostate cancer and eliminating the need for unnecessary biopsies. And even though the current commercial market for such tests is crowded, … [Read more...]

Genetic Testing

New Study Shows Viability of Using Ancestry to Compare Prostate Cancer Risk Across Populations

Ancestry has been shown to be a risk factor for prostate cancer. Unfortunately, we know very little about why men of certain races and ethnicities are more prone to get it, let alone how to use … [Read more...]


(-00000g2)